Furthermore, our study demonstrates that the IGF1R inhibitor linsitinib, known for its reported inhibition of tumor growth in various cancers, did not augment the inhibitory effect on tumor growth in Igf2-cKO mice and mice with specific fibroblast depletion (iDTRfl/flS100a4CreERT mice). The gene discussed is IGF1R; the disease is cancer.